Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: TEVA PHARMACEUTICALS USA, INC.
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-12-14 to 2023-12-19
Current total value of award: $2443150.08
Description: 8510325537!ADENOVIRUS TYPE 4 A